Acquired Long QT Syndrome

Author: A. John Camm  

Publisher: John Wiley & Sons Inc‎

Publication year: 2008

E-ISBN: 9781405146166

P-ISBN(Hardback):  9781405118385

Subject: R541 heart disease

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

In recent years there has been considerable interest in the diagnosis and understanding of ventricular repolarisation, particularly the QT interval prolongation and abnormal T and T/U wave morphology associated with torsades de pointes. Advances in ion channel cloning have greatly improved our understanding of the role of ionic channels in mediating cardiac repolarisation. Unfortunately, it is increasingly recognised that a number of drugs, both those associated with altering repolarisation, and others for non-cardiac conditions can increase the propensity for polymorphic ventricular tachycardia, syncope and even ventricular fibrillation and sudden death.

In this volume, arrhythmia specialists from St. George’s Hospital Medical School, London discuss the mechanisms behind QT prolongation and torsades de pointes. They focus particularly on the risk of individual cardiac and non-cardiac drugs in provoking long QT syndrome, providing a comprehensive review which will be useful for all electrophysiologists treating polymorphic ventricular tachycardias, and will expose important regulatory issues for pharmaceutical authorities and for the wider medical community.

Chapter

Contents

pp.:  7 – 8

Preface

pp.:  8 – 9

1 Introduction

pp.:  9 – 16

3 Measurement of QT interval and repolarization assessment

pp.:  32 – 68

4 Introduction to drug-induced long QT syndrome

pp.:  68 – 77

5 Risk of QT prolongation and torsades de pointes with antiarrhythmic drugs

pp.:  77 – 95

6 Risk of QT prolongation and torsades de pointes with antihistamines

pp.:  95 – 110

7 Risk of QT prolongation and torsades de pointes with psychotropic drugs

pp.:  110 – 129

8 Risk of QT prolongation and torsades de pointes with antimicrobial and antimalarial drugs

pp.:  129 – 148

9 Risk of QT prolongation and torsades de pointes with prokinetics and miscellaneous other drugs

pp.:  148 – 171

10 Acquired long QT syndrome secondary to cardiac conditions

pp.:  171 – 179

11 Acquired long QT syndrome secondary to noncardiac conditions

pp.:  179 – 190

12 Perspective on drug-induced repolarization changes

pp.:  190 – 199

Index

pp.:  199 – 208

The users who browse this book also browse